Literature DB >> 20713258

The 2009-2010 influenza pandemic: effects on pandemic and seasonal vaccine uptake and lessons learned for seasonal vaccination campaigns.

Gregory A Poland1.   

Abstract

Individual and national/cultural differences were apparent in response to the 2009-2010 influenza pandemic. Overall pandemic influenza immunization rates were low across all nations, including among healthcare workers. Among the reasons for the low coverage rates may have been a lack of concern about the individual risk of influenza, which may translate into a lack of willingness or urgency to be vaccinated, particularly if there is mistrust of information provided by public health or governmental authorities. Intuitively, a link between willingness to be vaccinated against seasonal influenza and against pandemic influenza exists, given the similarities in decision-making for this infection. As such, the public is likely to share common concerns regarding pandemic and seasonal influenza vaccination, particularly in the areas of vaccine safety and side effects, and personal risk. Given the public's perception of the low level of virulence of the recent pandemic influenza virus, there is concern that the perception of a lack of personal risk of infection and risk of vaccine side effects could adversely affect seasonal vaccine uptake. While governments are more often concerned about public anxiety and panic, as well as absenteeism of healthcare and other essential workers during a pandemic, convincing the public of the threat posed by pandemic or seasonal influenza is often the more difficult, and underappreciated task. Thus, appropriate, timely, and data-driven health information are very important issues in increasing influenza vaccine coverage, perhaps even more so in western societies where trust in government and public health reports may be lower than in other countries. This article explores what has been learned about cross-cultural responses to pandemic influenza, and seeks to apply those lessons to seasonal influenza immunization programs. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20713258     DOI: 10.1016/j.vaccine.2010.08.024

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  63 in total

1.  The expected emotional benefits of influenza vaccination strongly affect pre-season intentions and subsequent vaccination among healthcare personnel.

Authors:  Mark G Thompson; Manjusha J Gaglani; Allison Naleway; Sarah Ball; Emily M Henkle; Leslie Z Sokolow; Beth Brennan; Hong Zhou; Lydia Foster; Carla Black; Erin D Kennedy; Sam Bozeman; Lisa A Grohskopf; David K Shay
Journal:  Vaccine       Date:  2012-04-01       Impact factor: 3.641

2.  Clinical and demographic characteristics of seasonal influenza in pediatric patients with cancer.

Authors:  Silvana B Carr; Elisabeth E Adderson; Hana Hakim; Xiaoping Xiong; Xiaowei Yan; Miguela Caniza
Journal:  Pediatr Infect Dis J       Date:  2012-11       Impact factor: 2.129

3.  Association of Influenza Vaccination Coverage in Younger Adults With Influenza-Related Illness in the Elderly.

Authors:  Glen B Taksler; Michael B Rothberg; David M Cutler
Journal:  Clin Infect Dis       Date:  2015-09-09       Impact factor: 9.079

4.  Factors mediating seasonal and influenza A (H1N1) vaccine acceptance among ethnically diverse populations in the urban south.

Authors:  Paula M Frew; Julia E Painter; Brooke Hixson; Carolyn Kulb; Kathryn Moore; Carlos del Rio; Alejandra Esteves-Jaramillo; Saad B Omer
Journal:  Vaccine       Date:  2012-04-23       Impact factor: 3.641

5.  International society for disease surveillance conference 2011: building the future of public health surveillance.

Authors:  Daniel B Neill; Karl A Soetebier
Journal:  Emerg Health Threats J       Date:  2011-12-06

Review 6.  Healthcare worker compliance with seasonal and pandemic influenza vaccination.

Authors:  Claire Bellia; Michel Setbon; Patrick Zylberman; Antoine Flahault
Journal:  Influenza Other Respir Viruses       Date:  2013-09       Impact factor: 4.380

Review 7.  Live attenuated influenza vaccine (FluMist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults.

Authors:  Natalie J Carter; Monique P Curran
Journal:  Drugs       Date:  2011-08-20       Impact factor: 9.546

8.  Influenza vaccination among healthcare workers in Italy.

Authors:  Cristiano Alicino; Rocco Iudici; Ilaria Barberis; Chiara Paganino; Roberto Cacciani; Monica Zacconi; Angela Battistini; Dorotea Bellina; Anna Maria Di Bella; Antonella Talamini; Laura Sticchi; Alessandra Morando; Filippo Ansaldi; Paolo Durando
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

9.  Ten years (2004-2014) of influenza surveillance in Northern Italy.

Authors:  Elena Pariani; Antonella Amendola; Alessandra Piatti; Giovanni Anselmi; Alberto Ranghiero; Laura Bubba; Anna Maria Rosa; Laura Pellegrinelli; Sandro Binda; Liliana Coppola; Maria Gramegna; Alessandro Zanetti
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

10.  Activation of A1-adenosine receptors promotes leukocyte recruitment to the lung and attenuates acute lung injury in mice infected with influenza A/WSN/33 (H1N1) virus.

Authors:  Famke Aeffner; Parker S Woods; Ian C Davis
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.